Insights |

By Topic

Clear All

Dividend Stocks

Growth Stocks

Blue Chip Stocks

Market Trends

Economic Updates

Interest Rates & Inflation

Global Markets

Small Caps & Emerging Stocks

Retirement & Superannuation

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Consumer Discretionary

Guzman y Gomez (ASX:GYG) Surges 18% on Q3 Sales Beat: Is the Turnaround Finally Real?

The result showed stronger sales growth, improving margins, and positive signs from its delivery partnership, which helped drive the sharp share price move. Even so, investors still need to watch whether this momentum can continue and if the US expansion starts contributing in a meaningful way

Consumer Discretionary

Growth

Consumer Discretionary

Australia's Tourism Boom: ASX Consumer Discretionary Stocks to Watch in 2026

This article explores how Australia’s tourism recovery is creating fresh opportunities in ASX consumer discretionary stocks in 2026. It explains the structural drivers behind the rebound and highlights the listed companies most exposed to rising travel demand.

Consumer Discretionary

ASX 200

Growth Stocks

Small Caps & Emerging Stocks

Small-Cap Growth Stocks in Focus: Are ASX Micro-Caps Setting Up for a Re-Rating in 2026?

This article looks at whether the recent pullback in ASX micro-caps and small-cap growth stocks is a warning sign or a fresh opportunity for investors in 2026. It explains the earnings gap, valuation disconnect, sector tailwinds, and company-specific risks shaping the small-cap outlook.

Growth Stocks

Small Caps

Financials including Banking

Pepper Money (ASX:PPM) Falls Sharply on Challenger's Reduced Bid- But the Business Tells a Different Story

Challenger cut its offer for Pepper Money from A$2.60 to A$2.25 per share, creating fresh uncertainty around whether a deal will happen at all. That pushed PPM shares lower, even as its latest FY2025 numbers remained strong.

Financials including Banking

Interest Rates

ASX 200 Today

CSL's Leadership Shock: What CEO Exits Mean for ASX Healthcare

CSL Limited (ASX: CSL), Australia's largest healthcare company, dropped a bombshell on investors this week. On 10 February, the company announced that CEO Dr Paul McKenzie was leaving, effective immediately. Shares crashed around 5% in the closing auction, finishing at A$171.39. The very next morning, weak half-year earnings sent shares plunging again, falling as low as A$151.30 before recovering to around A$163.44, an eight-year low.

ASX 200 Today

CSL

Energy

Uranium's AI Power Trade Under Pressure: What It Means for ASX Miners

It has been a wild ride for uranium investors in 2026. Just weeks ago, uranium futures hit US$100 per pound, the highest price since February 2024. The reason? A growing belief that the AI boom would need nuclear power to keep the lights on in massive data centres. Money poured into the sector.

Energy

ASX 200

Insights |

By Topic

Guzman y Gomez (ASX:GYG) Surges 18% on Q3 Sales Beat: Is the Turnaround Finally Real?

Australia's Tourism Boom: ASX Consumer Discretionary Stocks to Watch in 2026

Small-Cap Growth Stocks in Focus: Are ASX Micro-Caps Setting Up for a Re-Rating in 2026?

Pepper Money (ASX:PPM) Falls Sharply on Challenger's Reduced Bid- But the Business Tells a Different Story

CSL's Leadership Shock: What CEO Exits Mean for ASX Healthcare

Uranium's AI Power Trade Under Pressure: What It Means for ASX Miners

Our friendly team is here to help.

ASR

Insights

Education

Documents